Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Tiziana Grafone"'
Publikováno v:
Oncology Reviews, Vol 6, Iss 1 (2012)
Hematopoiesis, the process by which the hematopoietic stem cells and progenitors differentiate into blood cells of various lineages, involves complex interactions of transcription factors that modulate the expression of downstream genes and mediate p
Externí odkaz:
https://doaj.org/article/76322914300f45aa92cce8987f9a9913
Autor:
Michela Palmisano, Tiziana Grafone, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli
Publikováno v:
Haematologica, Vol 92, Iss 9 (2007)
NPM1 mutations have been reported to be the most frequent mutations in acute myeloid leukemia (AML). They are associated with a wide spectrum of morphologic subtypes of AML, normal karyotype and FLT3 mutations. The high frequency of NPM1 mutations mi
Externí odkaz:
https://doaj.org/article/82efb5cbacbe493dbf67e2b31b706861
Autor:
Claudio Sorio, Maria Monne, Attilio Gabbas, Giovanna Piras, Cristina Tecchio, Fabrizio Vinante, Marco Murineddu, Simona Soverini, Ilaria Iacobucci, Tiziana Grafone, Andrea Mafficini, Marzia Vezzalini, Davide Pintani, Elisabetta Moratti, Giovanni Martinelli, Marco Della Peruta
Supplementary Table 2 from Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d3fea95a0e6a6eb6ed1c0267f18341d
https://doi.org/10.1158/0008-5472.22386605
https://doi.org/10.1158/0008-5472.22386605
Autor:
Claudio Sorio, Maria Monne, Attilio Gabbas, Giovanna Piras, Cristina Tecchio, Fabrizio Vinante, Marco Murineddu, Simona Soverini, Ilaria Iacobucci, Tiziana Grafone, Andrea Mafficini, Marzia Vezzalini, Davide Pintani, Elisabetta Moratti, Giovanni Martinelli, Marco Della Peruta
Chronic myelogenous leukemia (CML) is the most common myeloproliferative disease. Protein tyrosine phosphatase receptor type γ (PTPRG) is a tumor suppressor gene and a myeloid cell marker expressed by CD34+ cells. Downregulation of PTPRG increases c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e6c726dd7c04d6c98012219b978dcea
https://doi.org/10.1158/0008-5472.c.6501587
https://doi.org/10.1158/0008-5472.c.6501587
Autor:
Claudio Sorio, Maria Monne, Attilio Gabbas, Giovanna Piras, Cristina Tecchio, Fabrizio Vinante, Marco Murineddu, Simona Soverini, Ilaria Iacobucci, Tiziana Grafone, Andrea Mafficini, Marzia Vezzalini, Davide Pintani, Elisabetta Moratti, Giovanni Martinelli, Marco Della Peruta
Supplementary Table 1 from Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c1dce89e4677e7a49eabca61c7d53d
https://doi.org/10.1158/0008-5472.22386608
https://doi.org/10.1158/0008-5472.22386608
Autor:
Veronica Papa, P. L. Tazzari, Giovanni Martinelli, James A. McCubrey, Roberta Bortul, Camilla Evangelisti, Tiziana Grafone, Giovanna Tabellini, Am Martelli
Publikováno v:
Leukemia. 21:886-896
Insulin-like growth factor-I (IGF-I) and its receptor (IGF-IR) have been implicated in the pathophysiology of many human cancers, including those of hematopoietic lineage. We investigated the therapeutic potential of the novel IGF-IR tyrosine kinase
Autor:
Pier Luigi Tazzari, Giovanna Tabellini, Roberta Bortul, Giovanni Martinelli, Michele Baccarani, Camilla Evangelisti, Alberto M. Martelli, Tiziana Grafone, Anna Maria Billi
Publikováno v:
British journal of haematology
130 (2005): 716–725.
info:cnr-pdr/source/autori:G. TABELLINI, P.L. TAZZARI, R. BORTUL, C. EVANGELISTI, A.M. BILLI, T. GRAFONE, G. MARTINELLI, M. BACCARANI, A.M. MARTELLI,/titolo:Phosphoinositide 3-kinase%2FAkt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias,/doi:/rivista:British journal of haematology (Print)/anno:2005/pagina_da:716/pagina_a:725/intervallo_pagine:716–725/volume:130
130 (2005): 716–725.
info:cnr-pdr/source/autori:G. TABELLINI, P.L. TAZZARI, R. BORTUL, C. EVANGELISTI, A.M. BILLI, T. GRAFONE, G. MARTINELLI, M. BACCARANI, A.M. MARTELLI,/titolo:Phosphoinositide 3-kinase%2FAkt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias,/doi:/rivista:British journal of haematology (Print)/anno:2005/pagina_da:716/pagina_a:725/intervallo_pagine:716–725/volume:130
Recent studies suggest that the prosurvival signal transduction pathway involving phosphoinositide 3-kinase (PI3K)/Akt can confer an aggressive, apoptosis-resistant phenotype to acute leukaemia cells. We have investigated the effect of modulating thi
Autor:
Irina Mantovani, Emanuela Ottaviani, Pier Luigi Tazzari, Giovanni Martinelli, Tiziana Grafone, Anna Maria Billi, Alberto M. Martelli, Roberto Conte, Alessandra Cappellini, Francesca Ricci
Publikováno v:
British Journal of Haematology. 126:675-681
The phosphoinositide 3-kinase/Akt signalling pathway is a recently recognized important parameter in the prognosis and the response to treatment of acute myeloid leukaemia (AML). Akt kinase is activated by phosphorylation on Thr 308 and Ser 473. Acti
Autor:
Marilina Amabile, Carolina Terragna, Antonio De Vivo, Tiziana Grafone, Michele Cavo, Barbara Giannini, Delia Cangini, Sante Tura, Sonia Fabris, Nicoletta Testoni, Antonino Neri, Michele Baccarani, Patrizia Tosi, Emanuela Ottaviani, Claudia Cellini, Simona Soverini, Giovanni Martinelli, Deborah Ruggeri, Elena Zamagni, Francesca Bonifazi
Publikováno v:
Blood. 102:1588-1594
We used a sensitive real-time reverse transcription–polymerase chain reaction assay to quantify cyclin D1 mRNA levels in bone marrow samples collected at diagnosis from 74 newly diagnosed multiple myeloma (MM) patients who were randomized to underg
Autor:
Patrizia Tosi, Lucia Catani, Giuseppe Visani, Tiziana Grafone, R. Pastano, F Nocentini, Nicoletta Testoni, Emanuela Ottaviani, Pier Paolo Piccaluga, Luigi Gugliotta, Nicola Vianelli, Sante Tura, Alessandro Isidori, Giovanni Martinelli
Publikováno v:
European Journal of Haematology. 64:139-144
Early hemorrhagic death (within the first 10 d of treatment [EHD]) is reported as the main cause of death during induction therapy for acute promyelocytic leukemia (APL). In order to evaluate possible differences in the incidence of EHD during induct